Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 207.09M | 177.19M | 147.35M | 123.25M | 110.09M | 137.93M |
Gross Profit | 178.06M | 123.22M | 96.88M | 69.89M | 64.18M | 93.51M |
EBITDA | 130.24M | 124.52M | 102.45M | 77.40M | 70.59M | 94.24M |
Net Income | -70.72M | -122.65M | -188.29M | -84.54M | -147.58M | -292.53M |
Balance Sheet | ||||||
Total Assets | 4.33B | 4.05B | 4.06B | 4.18B | 4.47B | 4.66B |
Cash, Cash Equivalents and Short-Term Investments | 215.18M | 1.04B | 961.26M | 947.31M | 1.09B | 1.04B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 133.75M | 166.22M | 155.46M | 147.82M | 143.61M | 138.79M |
Stockholders Equity | 4.20B | 3.88B | 3.90B | 4.03B | 4.32B | 4.52B |
Cash Flow | ||||||
Free Cash Flow | 26.58M | 62.30M | 61.22M | 60.25M | 60.97M | 36.72M |
Operating Cash Flow | 33.77M | 77.27M | 72.12M | 69.66M | 80.60M | 54.35M |
Investing Cash Flow | -12.19M | -136.07M | -263.22M | -114.30M | 263.47M | 187.91M |
Financing Cash Flow | -28.59M | -22.23M | -32.24M | -210.04M | -48.49M | -145.47M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $2.66B | 13.65 | 5.58% | 2.91% | -19.93% | -43.35% | |
74 Outperform | HK$260.37B | 14.75 | 2.88% | 4.23% | 20.91% | -29.29% | |
69 Neutral | $79.15B | 20.82 | 2.17% | 1.73% | -30.38% | -43.73% | |
69 Neutral | HK$125.39B | 19.84 | 1.94% | 10.04% | -7.64% | -32.01% | |
56 Neutral | $13.77B | ― | -10.34% | 8.79% | -56.64% | -3398.20% | |
54 Neutral | $1.17B | 3.57 | 0.13% | 7.12% | -2.13% | -128.06% | |
50 Neutral | HK$826.20M | ― | -7.11% | 5.88% | 8.19% | 32.85% |